Daily Archives: 27/04/2021

*VMAT2 inhibitor? What’s that?* Valbenazine (Ingrezza) is a selective inhibitor of vesicular monoamine transporter 2 (VMAT 2). In April, 2017, it was approved by the FDA for the treatment of adults with tardive dyskinesia. It is the first medication ever to be FDA-approved for the treatment of tardive dyskinesia. What is VMAT 2? VMAT2 sounds […]

Summary of COVID Rx updated guideline*

*Summary of COVID Rx updated guideline* (Adopted from webinar held on 25/4/2021 conducted by Dept of H & FW, Govt of West Bengal, Presented by Prof Soumitra Ghosh, HOD Medicine, IPGME & R, Kolkata) *Virus doesn’t kill directly, it kills by immune inflammation.* Treatment must centre on the monitoring of clinical, biochemical and inflammatory parameters. […]